Clinical Trials Logo

Recurrent ER+ Breast Cancer clinical trials

View clinical trials related to Recurrent ER+ Breast Cancer.

Filter by:
  • None
  • Page 1

NCT ID: NCT02559544 Recruiting - Clinical trials for Metastatic ER+ Breast Cancer

[18F]Fluoroestradiol (FES) PET/CT Imaging to Evaluate in Vivo Estrogen Receptor Activity in Endocrine Refractory Recurrent or Metastatic Breast Cancer

Start date: May 2015
Phase: N/A
Study type: Interventional

Evaluate [18F]FES PET/CT uptake as a predictor of progression free survival in endocrine refractory recurrent or metastatic breast cancer patients starting a new therapy regimen including endocrine targeted therapy.